Role of MRI in the Early Diagnosis and Management of Acute Stroke and Its Impact on Turnaround Time in Emergency Settings

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

136 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-23

Study Completion Date

2026-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the role of stroke protocol in the early diagnosis and management of acute stroke and its effect on turnaround time (TAT) in emergency settings.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Mobile MRI for Immediate Radiological Acute Cerebral Lesion Evaluation in Stroke

NCT06262217

Stroke, Acute

RECRUITING

3 Tesla (3T) Stroke Medical Radiologic Technology (MRT) for Examining Mismatch in 1000+

NCT00715533

Acute Stroke Transient Ischemic Attack

COMPLETED

Stroke Lesion Pattern on MRI and Atrial Fibrillation

NCT02606890

Stroke Atrial Fibrillation

COMPLETED

Proving Utility of a New Field-cycling MRI Prototype in Acute Stroke Patients

NCT07004140

Stroke Acute

RECRUITING

Microstructure Imaging in Stroke Patients

NCT04118790

Fatigue Stroke, Acute Transient Ischemic Attack

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Acute stroke is a common and often devastating disorder; however, acute treatments that reduce long-term disability are available if patients present within the time window for treatment.

Computed tomography (CT) or magnetic resonance imaging (MRI) has been used in comprehensive stroke centers, although the role of advanced imaging in the improvement of stroke outcome remains controversial.

MRI offers advantages for the assessment of acute stroke. Changes of acute ischaemic injury are detectable sooner with MRI than with CT, especially with diffusion-weighted imaging, and ischaemic stroke diagnosis with MRI has greater interobserver and intraobserver reliability than CT, even in readers with little experience.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Magnetic Resonance Imaging Diagnosis Management Acute Stroke Turnaround Time Emergency Settings

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study group

Patients with acute stroke who are admitted to the emergency department.

Magnetic Resonance Imaging

Intervention Type DEVICE

Magnetic Resonance Imaging will be performed to all patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magnetic Resonance Imaging

Magnetic Resonance Imaging will be performed to all patients

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 years.
* Both sexes.
* Patients with acute stroke who are admitted to the emergency department.

Exclusion Criteria

* Contraindications to magnetic resonance imaging (MRI) or computed tomography (CT).
* Symptoms strongly suggestive of subarachnoid hemorrhage.
* Initiation of antithrombotic or thrombolytic treatment before the completion of both scans.
* Inability to complete both scans in time to allow thrombolytic treatment within three h of the onset of symptoms.
* Uncontrollable hypertension.
* Pregnant or lactating women.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No